Donna S. Whitlon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Donna S. Whitlon has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
M. Grover
Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
4 shared publicationsClaus-Peter Richter
Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Knowles Hearing Center, Northwestern University, Chicago, IL 60208, USA; Department of Biomedical Engineering, Northwestern University, Chicago, IL 60208, USA
3 shared publicationsM.T. Coulson
Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University
3 shared publicationsD. Tieu
Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
2 shared publicationsHunter Young
Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA
2 shared publicationsLyubov Czech
Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
2 shared publications
Latest Publications
- Open Access
- 21 April 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 163, 114674
Statins protect mice from high-decibel noise-induced hearing loss
- 21 April 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 163, 114674
Open AccessStatins protect mice from high-decibel noise-induced hearing loss
- 1 August 2019
- Published by Elsevier in Hearing Research
- Vol. 379, 69-78
Hearing differences in Hartley guinea pig stocks from two breeders
- 1 August 2019
- Published by Elsevier in Hearing Research
- Vol. 379, 69-78
Hearing differences in Hartley guinea pig stocks from two breeders
- Open Access
- 26 March 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-7
Sex Genotyping of Archival Fixed and Immunolabeled Guinea Pig Cochleas
For decades, outbred guinea pigs (GP) have been used as research models. Various past research studies using guinea pigs used measures that, unknown at the time, may be sex-dependent, but from which today, archival tissues may be all that remain. We aimed to provide a protocol for sex-typing archival guinea pig tissue, whereby past experiments could be re-evaluated for sex effects. No PCR sex-genotyping protocols existed for GP. We found that published sequence of the GP Sry gene differed from that in two separate GP stocks. We used sequences from other species to deduce PCR primers for Sry. After developing a genomic DNA extraction for archival, fixed, decalcified, immunolabeled, guinea pig cochlear half-turns, we used a multiplex assay (Y-specific Sry; X-specific Dystrophin) to assign sex to tissue as old as 3 years. This procedure should allow reevaluation of prior guinea pig studies in various research areas for the effects of sex on experimental outcomes.
- 26 March 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-7
Open AccessSex Genotyping of Archival Fixed and Immunolabeled Guinea Pig Cochleas
For decades, outbred guinea pigs (GP) have been used as research models. Various past research studies using guinea pigs used measures that, unknown at the time, may be sex-dependent, but from which today, archival tissues may be all that remain. We aimed to provide a protocol for sex-typing archival guinea pig tissue, whereby past experiments could be re-evaluated for sex effects. No PCR sex-genotyping protocols existed for GP. We found that published sequence of the GP Sry gene differed from that in two separate GP stocks. We used sequences from other species to deduce PCR primers for Sry. After developing a genomic DNA extraction for archival, fixed, decalcified, immunolabeled, guinea pig cochlear half-turns, we used a multiplex assay (Y-specific Sry; X-specific Dystrophin) to assign sex to tissue as old as 3 years. This procedure should allow reevaluation of prior guinea pig studies in various research areas for the effects of sex on experimental outcomes.
- Open Access
- 14 February 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-12
Fluvastatin protects cochleae from damage by high-level noise
Exposure to noise and ototoxic drugs are responsible for much of the debilitating hearing loss experienced by about 350 million people worldwide. Beyond hearing aids and cochlear implants, there have been no other FDA approved drug interventions established in the clinic that would either protect or reverse the effects of hearing loss. Using Auditory Brainstem Responses (ABR) in a guinea pig model, we demonstrate that fluvastatin, an inhibitor of HMG-CoA reductase, the rate-limiting enzyme of the mevalonate pathway, protects against loss of cochlear function initiated by high intensity noise. A novel synchrotron radiation based X-ray tomographic method that imaged soft tissues at micrometer resolution in unsectioned cochleae, allowed an efficient, qualitative evaluation of the three-dimensional internal structure of the intact organ. For quantitative measures, plastic embedded cochleae were sectioned followed by hair cell counting. Protection in noise-exposed cochleae is associated with retention of inner and outer hair cells. This study demonstrates the potential of HMG-CoA reductase inhibitors, already vetted in human medicine for other purposes, to protect against noise induced hearing loss.
- 14 February 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-12
Open AccessFluvastatin protects cochleae from damage by high-level noise
Exposure to noise and ototoxic drugs are responsible for much of the debilitating hearing loss experienced by about 350 million people worldwide. Beyond hearing aids and cochlear implants, there have been no other FDA approved drug interventions established in the clinic that would either protect or reverse the effects of hearing loss. Using Auditory Brainstem Responses (ABR) in a guinea pig model, we demonstrate that fluvastatin, an inhibitor of HMG-CoA reductase, the rate-limiting enzyme of the mevalonate pathway, protects against loss of cochlear function initiated by high intensity noise. A novel synchrotron radiation based X-ray tomographic method that imaged soft tissues at micrometer resolution in unsectioned cochleae, allowed an efficient, qualitative evaluation of the three-dimensional internal structure of the intact organ. For quantitative measures, plastic embedded cochleae were sectioned followed by hair cell counting. Protection in noise-exposed cochleae is associated with retention of inner and outer hair cells. This study demonstrates the potential of HMG-CoA reductase inhibitors, already vetted in human medicine for other purposes, to protect against noise induced hearing loss.
- Open Access
- 1 June 2017
- Published by Elsevier in Hearing Research
- Vol. 349, 177-181
Drug discovery for hearing loss: Phenotypic screening of chemical compounds on primary cultures of the spiral ganglion
- 1 June 2017
- Published by Elsevier in Hearing Research
- Vol. 349, 177-181
Open AccessDrug discovery for hearing loss: Phenotypic screening of chemical compounds on primary cultures of the spiral ganglion
- Open Access
- 2 November 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 15960
Novel High Content Screen Detects Compounds That Promote Neurite Regeneration from Cochlear Spiral Ganglion Neurons
The bipolar spiral ganglion neurons (SGN) carry sound information from cochlear hair cells to the brain. After noise, antibiotic or toxic insult to the cochlea, damage to SGN and/or hair cells causes hearing impairment. Damage ranges from fiber and synapse degeneration to dysfunction and loss of cells. New interventions to regenerate peripheral nerve fibers could help reestablish transfer of auditory information from surviving or regenerated hair cells or improve results from cochlear implants, but the biochemical mechanisms to target are largely unknown. Presently, no drugs exist that are FDA approved to stimulate the regeneration of SGN nerve fibers. We designed an original phenotypic assay to screen 440 compounds of the NIH Clinical Collection directly on dissociated mouse spiral ganglia. The assay detected one compound, cerivastatin, that increased the length of regenerating neurites. The effect, mimicked by other statins at different optimal concentrations, was blocked by geranylgeraniol. These results demonstrate the utility of screening small compound libraries on mixed cultures of dissociated primary ganglia. The success of this screen narrows down a moderately sized library to a single compound which can be elevated to in-depth in vivo studies and highlights a potential new molecular pathway for targeting of hearing loss drugs.
- 2 November 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 15960
Open AccessNovel High Content Screen Detects Compounds That Promote Neurite Regeneration from Cochlear Spiral Ganglion Neurons
The bipolar spiral ganglion neurons (SGN) carry sound information from cochlear hair cells to the brain. After noise, antibiotic or toxic insult to the cochlea, damage to SGN and/or hair cells causes hearing impairment. Damage ranges from fiber and synapse degeneration to dysfunction and loss of cells. New interventions to regenerate peripheral nerve fibers could help reestablish transfer of auditory information from surviving or regenerated hair cells or improve results from cochlear implants, but the biochemical mechanisms to target are largely unknown. Presently, no drugs exist that are FDA approved to stimulate the regeneration of SGN nerve fibers. We designed an original phenotypic assay to screen 440 compounds of the NIH Clinical Collection directly on dissociated mouse spiral ganglia. The assay detected one compound, cerivastatin, that increased the length of regenerating neurites. The effect, mimicked by other statins at different optimal concentrations, was blocked by geranylgeraniol. These results demonstrate the utility of screening small compound libraries on mixed cultures of dissociated primary ganglia. The success of this screen narrows down a moderately sized library to a single compound which can be elevated to in-depth in vivo studies and highlights a potential new molecular pathway for targeting of hearing loss drugs.
- 31 August 2011
- Published by Elsevier in Hearing Research
- Vol. 278 (1-2) , 1
Introduction: Spiral ganglion neurons
- 31 August 2011
- Published by Elsevier in Hearing Research
- Vol. 278 (1-2) , 1
Introduction: Spiral ganglion neurons
- 1 November 2010
- Published by Elsevier in Neuroscience
- Vol. 171 (1) , 23-30
Purification and transfection of cochlear Schwann cells
- 1 November 2010
- Published by Elsevier in Neuroscience
- Vol. 171 (1) , 23-30
Purification and transfection of cochlear Schwann cells
- 1 June 2009
- Published by Elsevier in Neuroscience
- Vol. 161 (1) , 227-235
Spontaneous association of glial cells with regrowing neurites in mixed cultures of dissociated spiral ganglia
- 1 June 2009
- Published by Elsevier in Neuroscience
- Vol. 161 (1) , 227-235
Spontaneous association of glial cells with regrowing neurites in mixed cultures of dissociated spiral ganglia